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Abstract Whereas immunization coverage has been re-
peatedly assessed in the Swiss population, little is known
about the timely administration of universally recom-
mended immunizations in Switzerland and elsewhere. The
goal of this study was to determine compliance with of-
ficial standard immunization recommendations in pre-
school and school-aged children in Basel, Switzerland,
focusing on coverage rates and timely administration. Of a
cohort of children entering kindergarten and third-grade
primary school in Basel in 2001, 310 and 310, respectively,
were identified in proportion to the overall age-appropriate
populations in the four city districts. Foreign-born children
were excluded. The data were extracted from immunization
records provided voluntarily by parents. Coverage for three
doses of diphtheria, tetanus, and poliomyelitis vaccines
was >95% and <90% for pertussis and Hib. The rates of
age-appropriate booster doses were significantly lower,
especially for pertussis and Hib (<60%). Cumulative
coverage for measles, mumps, and rubella (MMR) was
<90% for the first dose and 33% for the second dose by 10
years of age. All immunizations were administered with
significant delays. Coverage for the first three doses of
DTP combination vaccines did not reach 90% before 1 year
of age and, for the first dose of MMR, a plateau just below
80% was not reached before 3 years of age. Delayed ad-
ministration of immunizations in childhood, as well as
complete lack of booster doses in a significant fraction of
children, with important implications for public health have
been discovered in this study. This may lead to fatal disease
in individuals, epidemics in the community, and threatens
national and international targets of disease elimination,
such as measles and congenital rubella syndrome.
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vaccine . OPV: Oral poliomyelitis vaccine .
Hib: Haemophilus influenzae type b .
MMR: Measles, mumps, rubella .
HBV: hepatitis B vaccine
Introduction
Compliance with recommended immunizations is usually
estimated based on immunization coverage in specific age
groups. These data, however, do not allow the assessment
of timely immunization and, therefore, information on this
is scarce in Switzerland and elsewhere [1, 4, 5, 8–10, 12,
14]. This is unfortunate, since knowledge on the extent
of timely immunization, especially in children, would be
useful for the improved control of vaccine-preventable
diseases. If immunizations are administered with signifi-
cant delays, individual as well as herd immunity is sub-
optimal and, not surprisingly, outbreaks of diseases such as
pertussis or measles will occur [11, 13].
The current Swiss standard immunization plan in child-
hood comprises vaccinations against nine diseases, i.e.,
DTPa-IPV-Hib (at 2, 4, 6, and 15–24 months of age),
MMR (12 and 15–24 months), DTPa-IPV (4–7 years), and
Td and HBV (11–15 years) [16]. Immunization against Hib
has been recommended since November 1991. The forth
and fifth dose of pertussis vaccine have been introduced
in 1996, as was a second dose for MMR (at 4–7 years,
recently changed to 15–24 months). Immunizations in
Switzerland are usually administered by pediatricians and
general practitioners in private practices; in addition, catch-
up immunizations are frequently offered by the School
Health Services in kindergarten and schools. Moreover,
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computer-based reminder systems are used by some phy-
sicians, but the extent of use of this procedure is unknown.
The goal of this prospective, exploratory cohort study
was to estimate immunization coverage and timely admin-
istration in kindergarten and school-aged children in Basel,
Switzerland, as a basis for targeted activities for improve-
ment in the future.
Methods
Study cohort and data collection
As part of regular standard procedures performed by the
local School Health Service, immunization records of all
children admitted to the first year of kindergarten or third
year of primary school are assessed on a voluntary basis in
the Canton of Basel every year. Age-appropriate coverage
is documented and individual recommendations for catch-
up immunizations are given to parents in written form. For
the purpose of this study, performed in 2001, not only the
numbers of specific immunizations, but also, each child’s
exact age at each immunization was recorded.
In the Canton of Basel, yearly assessment of immuni-
zation rates is performed in a pre-determined sequence of
visits to all kindergarten and schools. The Canton is di-
vided into four districts and the numbers of inhabitants and
proportions of children are not equally distributed. To achieve
a proportionate and representative study sample, a total of
310 kindergarten and 310 school children were selected
from the four districts according to the overall age-appro-
priate distribution of children. The study size of 310 chil-
dren per cohort was determined based on the following
assumptions: a yearly cohort of approximately 1,500–1,600
children entering the kindergarten/school system in Basel; a
study participation rate (per protocol) of 50–60%; at least
10% of all children residing in Basel were to be included in
the study.
Study enrollment was done in a consecutive fashion
until the pre-determined number of study subjects was
reached. Children who were not born and had not lived in
Switzerland when they were 2 months of age (and, there-
fore, were not necessarily immunized according to the Swiss
schedule) and children without available immunization
records were excluded from the per protocol analysis.
    Reasons for Exclusion
Children enrolled: n=620 
(100%)
Lack of immunization records: n=73  (11.8%)
Foreign born: n=42 (6.8%)
Included in final analysis: n=505 
(81.5%)
Fig. 1 Study flow chart
Table 1 Immunization coverage in the 505 study subjects
≥1 dose, N (%) ≥2 doses, N (%) ≥3 doses, N (%) ≥4 doses, N (%) ≥5 doses, N (%)
Diphtheria 498 (98.6) 496 (98.2) 491 (97.2) 457 (90.5) 192 (71.4)*
Tetanus 499 (98.8) 498 (98.6) 492 (97.4) 457 (90.5) 190 (70.6)*
Pertussis 468 (92.7) 456 (90.3) 437 (86.5) 281 (55.6) 9 (3.5)**
Hib*** 292 (96.1) 286 (94.1) 265 (87.2) 155 (51.0) n.a.
Poliomyelitis 499 (98.8) 498 (98.6) 488 (96.6) 431 (85.3) 158 (58.7)*
Measles 449 (88.9) 135 (50.2)* n.a. n.a. n.a.
Mumps 443 (87.7) 135 (50.2)* n.a. n.a. n.a.
Rubella 440 (87.1) 135 (50.2)* n.a. n.a. n.a.
n.a. not applicable
* Percentage refers to 269 children born before 1 January 1994 (i.e., >7 years of age during study period)
** Percentage refers to 258 children born between 1 January 1991 (i.e., eligible for the 5-dose recommendation established in 1996) and 31
December 1993 (i.e., >7 years of age during study period)
*** Percentage refers to 304 children born 1 January 1992 or later (i.e., eligible for Hib immunizations in infancy, recommended since 1991)
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Definitions
In accordance with the Swiss national immunization re-
commendations, timely immunization was defined as follows:
. For doses 1–3 of DTPa (doses 1 and 2, if DT only),
OPV or IPV, and Hib: administered with less than 4
weeks delay
. For dose 4 of DTPa (dose 3, if DT only), OPVor IPV,
and Hib: administered before second birthday
. For 1st dose of MMR: administered before 24 months
of age
. For 2nd dose of MMR: administered before seventh
birthday
Statistical analysis
Statistical analyses were performed by the use of SPSS
version 10.0 (SPSS Inc., Chicago, USA).
Ethical approval
The study protocol was approved by the University of Basel
Medical Faculty Ethical Committee. As a standard proce-
dure, the parents were informed via letter about the purpose
of the assessment of immunization status and were asked
to bring their child’s personal immunization records to
kindergarten or school on a specific date for inspection by
members of the School Health Service on a voluntary basis.
Children were considered to be “foreign born” if the first
immunization in their first year of life had been admin-
istered outside Switzerland.
Results
Characteristics of the study participants
There were 1,625 children entering kindergarten and 1,518
children entering third grade primary school in Basel in
2001. The relative distributions in the four districts were
35.1%, 20.7%, 30.3%, and 13.8% for the new kindergarten
entrees and 35.0%, 22.2%, 28.2%, and 14.6% for the third
grade entrees. Accordingly, the first 109 (35.2%), 64
(20.6%), 94 (30.3%), and 43 (13.9%) of kindergarten
children in the four respective districts were selected for
study participation in chronological order. The respective
figures for the third grade entrees were 109, 68, 88, and 45.
Of the 620 children enrolled, 115 (18.6%) were excluded
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Fig. 2 Cumulative vaccination
coverage with diphtheria vac-
cine doses 1–3 in 304 children
with recommended time points
at 2, 4, and 6 months of age.
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Fig. 3 Cumulative vaccination coverage with a forth dose of
pertussis component vaccine in 236 children born in September
1994 or later, and in the total study cohort (n=505). Squares children
born September 1994 or later (n=236). Diamonds all study children
(n=505)
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for reasons as stated in Fig. 1. The remaining 236 kin-
dergarten children were 5.2 years old on average (inter-
quartile range: 4.7–6.4) and the 269 school-aged children
were 9.4 years of age (inter-quartile range: 8.5–10.7).
There were 241 girls (47.7%) and 264 boys.
Immunization coverage
The overall immunization rates are demonstrated in
Table 1. As can be seen, coverage for the primary series
(three doses) was >95% for diphtheria, tetanus, and polio-
myelitis and <90% for pertussis and Hib. However, the
rates of recommended booster doses were significantly lower,
especially for pertussis and Hib. Specifically, coverage for
the fifth dose of pertussis was disappointingly low. Also,
coverage for MMR was below 90% for the first dose in the
total study cohort and approximately 50% for the second
dose in children 7 years of age or older at the time of the
study.
Timely administration of immunization
For the assessment of timely immunization, the following
analysis was restricted to 304 children born after 31 De-
cember 1991, when the recommended time points for DTP
were changed from 2–3–4 to 2–4–6 months of age. In
Fig. 2, cumulative coverage of the first three doses of
diphtheria immunization is demonstrated to exemplify
vaccination with DTP combination vaccines. As can be
seen, the 90% threshold was reached with significant delay,
i.e., at 110 days, 205 days, and 370 days for doses 1–3.
A forth dose of pertussis vaccine to be administered at
15–24 months of age was introduced in Switzerland in
January 1996. To assess compliance and timely adminis-
tration of this recommendation, the cumulative vaccination
coverage of children who were 15 months of age or older in
January 1996 is demonstrated in Fig. 3 in comparison to the
total study cohort. By 2 years of age, approximately 65% of
young children had received a forth dose, but a plateau is
reached just below 80% at 4 years of age. This indicates not
only suboptimal overall coverage, but also delayed admin-
istration in those who are immunized at all. Furthermore,
compliance with the forth dose was also analyzed in the
total study cohort, because the forth dose has been rec-
ommended as a catch-up immunization in children older
than 15–24 months of age. By 10 years of age, 55% of all
study children had received the reinforcing forth dose.
Finally, cumulative coverage with two doses of measles
containing vaccine (exemplary for MMR) was evaluated
(Fig. 4). By 2 years of age, the end of the recommended
time period for the first dose, 75% had been immunized
once. Coverage increased gradually to 82%, 86%, and 88%
at 3, 4, and 7 years (school entry) of age, respectively, but
remained below 90% throughout all the age groups in-
vestigated in this study. Administration of the second dose
was even more retarded: by 7 years of age, the end of the
recommended time period relevant for children included in
this study, 19% had received a second dose of measles
containing vaccines. The coverage for the two doses of
measles vaccines was 33% in the total study cohort (Fig. 4),
whereas in children 7 years of age or older, the rate was
approximately 50% (Table 1).
Discussion
In this study, we prospectively assessed immunization
coverage and—for the first time in Switzerland—timely
administration of generally recommended vaccinations in a
large cohort of kindergarten and school-aged children.
Overall, coverage for the primary series of immunizations
against diphtheria, tetanus, and poliomyelitis was excellent
(above 95%) and was acceptable (close to 90%) for
pertussis and Hib. However, coverage rates for booster
doses were significantly lower, which is of great concern,
given that vaccine-induced immunity will wane over time
[20]. Furthermore, coverage rates for the first and second
dose of MMR were below the targets established by the
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coverage with one and two
doses of measles containing
vaccine in 505 study children
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WHO [21]. Unfortunately, these findings are in line with
previous surveys performed in various areas of Switzerland
and elsewhere in Europe, and jeopardize the goal of the
elimination of measles and congenital rubella syndrome by
the year 2010 [21]. Reasons for less than optimal immu-
nization rates in a number of western European countries
are numerous, and further efforts such as reminder recall
systems, education of professionals and the public, as well
as providing more opportunities for vaccination are needed
for improvement [2].
Data on timely administration of recommended child-
hood immunizations are rare, especially in Europe [3, 8]. In
a study performed in Germany in 1999, only 40–56% of
children had received their primary series of immunizations
against DTP, Hib, polio, and hepatitis B [8]. At 24 months
of age, the rates were in the range of 73–90% and 53–62%
for primary and booster immunizations, respectively. With
regards to MMR, 73% of children had received their first
dose by 2 years of age.
A retrospective cohort study among children who en-
tered public schools in Chicago, USA, in 2001 and 2002
revealed that only 31% of children had received all of the
recommended 2–4–6 month immunizations by 7 months of
age, and the percentage increased to merely 64% at 13
months of age [5]. With regards to administration of the
first dose of measles containing vaccine, the initial delay
was also significant, although by the time of school entry,
97% were immunized. The authors concluded that striking
immunization delays exist, which require more attention.
Similar results were obtained from the 2003 National
Immunization Survey in the USA, which was designed to
estimate vaccination coverage for children age 19–35
months [10]. In children up to 24 months of age, the cu-
mulative mean delay of recommended immunizations was
172 days, i.e., 6 months. Specifically, 9% (regarding polio)
to 21% (regarding Hib) of all children had delays of more
than 6 months. The authors postulated that greater em-
phasis should be put on minimizing the time spent in-
completely protected from vaccine-preventable diseases,
especially in young children.
In comparison, our findings are similarly worrisome and
indicate a need for action. With regards to the primary
series of DTP, approximately 65% of children were com-
pletely immunized by 7 months of age, and so were 90% by
1 year of age (Fig. 2). By 3.5 years of age, 18 months after
the latest recommended time point, coverage for the forth
dose of pertussis reached a plateau at approximately 80% in
children born from September 1994 onwards. Of concern,
coverage for the four doses was below 60% for the total
study population. This indicates that many physicians do
not comply with the national recommendation for catch-up
immunizations against pertussis in older children and,
therefore, herd immunity in the community can not be
expected. Not surprisingly, pertussis epidemics continue to
occur in school-aged children in Switzerland [11].
With regards to measles, usually given as MMR, 75% of
children had received their first dose by 2 years of age, and
coverage only increased slowly thereafter to reach 89%
by 10 years of age. Again, catch-up immunizations were
rarely applied after the recommended age for the first dose,
i.e., the second year of life. Importantly, the concept of
optimal protection by use of a two-dose schedule for MMR
has not been implemented at a high level in our area. At
school entry, only 20% of children had received a second
dose and the rate did not exceed 33% by 10 years of age.
Our study has some limitations. First and importantly,
our study design did not allow us to assess the reasons for
delay or complete lack of specific immunizations. Previous
studies in other communities have revealed several factors
which contribute to under-immunization. On the health
care provider side, these include missed opportunities for
immunization, misconceptions about the importance of
timely immunization, inappropriate contraindications, and
lack of recall systems to identify under-immunized children
[18]. On the family side, refusal of specific vaccinations,
birth order (second or later born), less educated mother, and
one-parent-family status have been identified as risk factors
for under-immunization in children [1, 9, 15, 17].
Second, the assessment of immunization status relied on
written documentation in a child’s official immunization
booklet. No efforts were made to verify how accurate these
documents were. Therefore, we may have misclassified
some children as not immunized when, in fact, the respec-
tive vaccination had been performed but not documented.
Although vaccination coverage, therefore, might have been
underestimated, this would not create a bias for analyses of
delayed administration.
Third, about 18% of the potential study children were
excluded from analyses because they were either of foreign
birth or no immunization records were available, either
because of parental refusal to participate or due to loss of
records. Unfortunately, the design of our study did not
allow us to discriminate “refusal to participate” and “loss of
documents” as reasons for exclusion, as this question had
not been asked formally. For this reason, we do not know if
and to which direction this might have biased our findings.
In our daily experience, foreign-born children have higher
or lower immunization rates than Swiss children, depend-
ing on their country of origin. In contrast, the children of
parents who hesitate to reveal immunization records fre-
quently have immunization gaps. Therefore, our estimates
on vaccination coverage may be too optimistic, but again,
we do not think that there would be a strong bias on the
overall findings of delayed immunizations.
In conclusion, we provide evidence for less than optimal
coverage of and significant delays in generally recom-
mended immunizations in one specific area of Switzerland.
We have no reason to believe that the situation would be
significantly different in other parts of the country. This is
of great concern and has important implications for public
health. Specifically, the timely start of vaccination is im-
portant in light of the rapid waning of transplacental
immunity (e.g., against measles) in the first year of life and
major health threats for infants caused by vaccine-pre-
ventable infectious diseases, such as pertussis and invasive
Hib disease [7, 19]. Further, delayed or even completely
missing booster doses puts individuals at unnecessary risk
of disease due to waning immunity over time and puts the
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whole community at risk of epidemics [6]. Greater efforts
are needed to decrease the duration of nonprotection caused
by incomplete and delayed immunizations.
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